Jane Griffiths, Company Group Chairman of Janssen EMEA, explains how the relationship between the industry and patients is evolving.
To her, pharmaceutical companies are more than ever patient-centric. They are developing solutions and processes to improve interactions with patients.
One way this is being done is through greater transparency, with the disclosure of all transfers of values. This has come with communications on the reasons why pharma companies work with HCPs and HCOs.
To read the full article: